123 related articles for article (PubMed ID: 2784108)
21. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
[TBL] [Abstract][Full Text] [Related]
22. CD3-associated alpha/beta and gamma/delta heterodimeric receptors are expressed by distinct populations of CD4- CD8- thymocytes.
Miescher GC; Howe RC; Lees RK; MacDonald HR
J Immunol; 1988 Mar; 140(6):1779-82. PubMed ID: 2964483
[TBL] [Abstract][Full Text] [Related]
23. Opposite CD4/CD8 lineage decisions of CD4+8+ mouse and rat thymocytes to equivalent triggering signals: correlation with thymic expression of a truncated CD8 alpha chain in mice but not rats.
Mitnacht R; Bischof A; Torres-Nagel N; Hünig T
J Immunol; 1998 Jan; 160(2):700-7. PubMed ID: 9551905
[TBL] [Abstract][Full Text] [Related]
24. Anti-CD3 + IL-2-stimulated murine killer cells. In vitro generation and in vivo antitumor activity.
Anderson PM; Blazar BR; Bach FH; Ochoa AC
J Immunol; 1989 Feb; 142(4):1383-94. PubMed ID: 2521662
[TBL] [Abstract][Full Text] [Related]
25. Clonogenic potential of murine CD4+8+ thymocytes. Direct demonstration using a V beta 6-specific proliferative stimulus in Mlsa mice.
Howe RC; MacDonald HR
J Immunol; 1989 Aug; 143(3):793-7. PubMed ID: 2526174
[TBL] [Abstract][Full Text] [Related]
26. A novel surface molecule expressed by long-term cultured T and natural killer cells is involved in cell activation.
Ferrini S; Cantoni C; Ciccone E; Biassoni R; Prigione I; Bottino C; Venzano P; Moretta L
Eur J Immunol; 1991 Sep; 21(9):1981-7. PubMed ID: 1832383
[TBL] [Abstract][Full Text] [Related]
27. Autoreactive T cells in normal mice: unrestricted recognition of self peptides on dendritic cell I-A molecules by CD4-CD8- T cell receptor alpha/beta+ T cell clones expressing V beta 8.1 gene segments.
Seman M; Boudaly S; Roger T; Morisset J; Pham G
Eur J Immunol; 1990 Jun; 20(6):1265-72. PubMed ID: 2142457
[TBL] [Abstract][Full Text] [Related]
28. Major histocompatibility complex-linked specificity of gamma delta receptor-bearing T lymphocytes.
Matis LA; Cron R; Bluestone JA
Nature; 1987 Nov 19-25; 330(6145):262-4. PubMed ID: 3499575
[TBL] [Abstract][Full Text] [Related]
29. The requirements for triggering of lysis by cytolytic T lymphocyte clones. II. Cyclosporin A inhibits TCR-mediated exocytosis by only selectively inhibits TCR-mediated lytic activity by cloned CTL.
Lancki DW; Kaper BP; Fitch FW
J Immunol; 1989 Jan; 142(2):416-24. PubMed ID: 2492047
[TBL] [Abstract][Full Text] [Related]
30. Exogenous IL-7 promotes the growth of CD3-CD4-CD8-CD44+CD25+/- precursor cells and blocks the differentiation pathway of TCR-alpha beta cells in fetal thymus organ culture.
Plum J; De Smedt M; Leclercq G
J Immunol; 1993 Apr; 150(7):2706-16. PubMed ID: 8095954
[TBL] [Abstract][Full Text] [Related]
31. Deficient CD4+ T cell proliferation in the class 1 MHC-restricted 2C TCR-transgenic mouse.
Chen FL; Kung JT
J Immunol; 1996 Mar; 156(6):2036-44. PubMed ID: 8690890
[TBL] [Abstract][Full Text] [Related]
32. CD4 and CD8 are positive regulators of T cell receptor signal transduction in early T cell differentiation.
Gilliland LK; Teh HS; Uckun FM; Norris NA; Teh SJ; Schieven GL; Ledbetter JA
J Immunol; 1991 Mar; 146(6):1759-65. PubMed ID: 1706380
[TBL] [Abstract][Full Text] [Related]
33. MHC class I-selected CD4-CD8-TCR-alpha beta+ T cells are a potential source of IL-4 during primary immune response.
Leite-de-Moraes MC; Herbelin A; Machavoine F; Vicari A; Gombert JM; Papiernik M; Dy M
J Immunol; 1995 Nov; 155(10):4544-50. PubMed ID: 7594451
[TBL] [Abstract][Full Text] [Related]
34. Lysis of tumor cells by CD3+4-8-16+ T cell receptor alpha beta- clones, regulated via CD3 and CD16 activation sites, recombinant interleukin 2, and interferon beta 1.
van de Griend RJ; Tax WJ; van Krimpen BA; Vreugdenhil RJ; Ronteltap CP; Bolhuis RL
J Immunol; 1987 Mar; 138(5):1627-33. PubMed ID: 2949018
[TBL] [Abstract][Full Text] [Related]
35. B7 costimulates proliferation of CD4-8+ T lymphocytes but is not required for the deletion of immature CD4+8+ thymocytes.
Tan R; Teh SJ; Ledbetter JA; Linsley PS; Teh HS
J Immunol; 1992 Nov; 149(10):3217-24. PubMed ID: 1385518
[TBL] [Abstract][Full Text] [Related]
36. Selective stimulation of thymocyte precursors mediated by specific cytokines. Different CD3+ subsets are generated by IL-1 versus IL-2.
Gotlieb WH; Durum SK; Gregorio TA; Mathieson BJ
J Immunol; 1991 Apr; 146(7):2262-71. PubMed ID: 1706392
[TBL] [Abstract][Full Text] [Related]
37. Growth-promoting activity of IL-1 alpha, IL-6, and tumor necrosis factor-alpha in combination with IL-2, IL-4, or IL-7 on murine thymocytes. Differential effects on CD4/CD8 subsets and on CD3+/CD3- double-negative thymocytes.
Suda T; Murray R; Guidos C; Zlotnik A
J Immunol; 1990 Apr; 144(8):3039-45. PubMed ID: 1969882
[TBL] [Abstract][Full Text] [Related]
38. Stimulation via the CD3 and CD28 molecules induces responsiveness to IL-4 in CD4+CD29+CD45R- memory T lymphocytes.
Damle NK; Doyle LV
J Immunol; 1989 Sep; 143(6):1761-7. PubMed ID: 2570801
[TBL] [Abstract][Full Text] [Related]
39. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
[TBL] [Abstract][Full Text] [Related]
40. Antibodies to the L3T4 and Lyt-2 molecules interfere with antigen receptor-driven activation of cloned murine T cells.
Moldwin RL; Havran WL; Nau GJ; Lancki DW; Kim DK; Fitch FW
J Immunol; 1987 Aug; 139(3):657-64. PubMed ID: 2955046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
